LRRK2 and Parkinson disease: This conclusion aligns with the positive correlation between activating mutations in LRRK2, which favor this kinase over LRRK1, and the progression of PD (28), as well as with the detection of phosphoRab12 under basal conditions only in cells that express high levels of LRRK2.